Jan 27, 2020 by Brian Orelli, PhDFDA Approves Merck's Dificid for Infections in ChildrenThe approval includes a new oral suspension version of the drug.
Jan 27, 2020 by Brian Orelli, PhDEli Lilly and Incyte's Olumiant Helps Eczema Patients in a Late-Stage Clinical TrialThe results could help expand use of the drug that's currently approved to treat rheumatoid arthritis.
Jan 27, 2020 by Brian Orelli, PhDSorrento Therapeutics Rejects Unsolicited Acquisition OfferThe offer undervalued the company, according to the board.
Jan 24, 2020 by Brian Orelli, PhDHere's Why Epizyme Is Down on Good News TodayThe biotech's FDA approval was priced in, but the company still has potential.
Jan 24, 2020 by Brian Orelli, PhDHere's Why Inovio Pharmaceuticals Jumped Higher TodayThe company is developing a vaccine against the 2019-nCoV coronavirus.
Jan 23, 2020 by Brian Orelli, PhDFDA Approves Epizyme's Sarcoma Drug TazverikThe accelerated approval will need to be confirmed by an ongoing clinical trial in previously untreated patients.
Jan 23, 2020 by Brian Orelli, PhDIntuitive Surgical Grows Profits by 22% in the Fourth QuarterA lower tax rate and an increase in interest and other income helped boost the company's bottom line.
Jan 23, 2020 by Brian Orelli, PhDAbbott's Proclaim XR Neurostimulation Implant Device Said to Reduce PainThe recently launched system has helped the medical device company's struggling neurology business.
Jan 22, 2020 by Brian Orelli, PhDAkcea and Ionis' Triglyceride-Lowering Drug Works in Mid-Stage Clinical TrialThe drug will advance to studies in familial chylomicronemia syndrome and other diseases that result in high triglyceride levels.
Jan 22, 2020 by Brian Orelli, PhDHere's Why Exact Sciences Jumped Higher TodayPotential competitors for its colon cancer test Cologuard aren't ready for prime time.
Jan 21, 2020 by Brian Orelli, PhDAstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate CancerThe blockbuster drug is already approved for three other types of tumors.
Jan 15, 2020 by Brian Orelli, PhDHere's Why Momenta Pharmaceuticals Stock Jumped Higher Again TodayThe biotech makes progress on developing its pipeline.
Jan 14, 2020 by Brian Orelli, PhDAbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque PsoriasisThe results should help the upstart drug to compete with Cosentyx.
Jan 14, 2020 by Brian Orelli, PhDHere's Why Stemline Therapeutics Dropped TodayThe launch of blood cancer drug Elzonris is slowing.
Jan 13, 2020 by Brian Orelli, PhDExact Sciences Reports Fourth Quarter Preliminary ResultsSales of its legacy business were up 61% year over over while revenue from recently-acquired Genomic Health grew 13%.
Jan 13, 2020 by Brian Orelli, PhDTeladoc Health Plans to Acquire InTouch Health for $600 MillionThe acquisition increases the clinical uses of Teladoc's telemedicine platform.
Jan 11, 2020 by Brian Orelli, PhDAll the 2020 Pre-JPM News Healthcare Investors Need to KnowThe Super Bowl of healthcare kicked off early for these companies.
Jan 9, 2020 by Brian Orelli, PhDIntuitive Surgical Reports Preliminary Fourth Quarter 2019 ResultsRevenue increased by 22% to $1.28 billion.
Jan 9, 2020 by Brian Orelli, PhDBristol-Myers Squibb's Celgene Unit Backs Out of a $55 Million SettlementNot enough defendants were willing to sign onto the class action.
Jan 9, 2020 by Brian Orelli, PhDHere's Why DBV Technologies Shares Jumped Higher TodayLong-term data suggests longer treatments with Viaskin Peanut improve peanut tolerance.
![intuitive-da-vinci-xi-patient-cart-front-view-cream[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F554556%2Fintuitive-da-vinci-xi-patient-cart-front-view-cream1.jpg&w=384&op=resize)
![intouch-vici-image-2[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F553261%2Fintouch-vici-image-21.jpg&w=384&op=resize)
![intuitive-da-vinci-xi-patient-cart-front-view-cream[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F553045%2Fintuitive-da-vinci-xi-patient-cart-front-view-cream1.jpg&w=384&op=resize)
